Your browser doesn't support javascript.
loading
Pharmacokinetic study of sodium trans[tetrachlorobis(1H-indazole)-ruthenate (III)]/-indazole hydrochloride (1:1.1) (FFC14A) in patients with solid tumors.
Henke, M M; Richly, H; Drescher, A; Grubert, M; Alex, D; Thyssen, D; Jaehde, U; Scheulen, M E; Hilger, R A.
Affiliation
  • Henke MM; Universitatsklinikum Essen, Essen, Germany. magdalena.henke@uni.essen.de
Int J Clin Pharmacol Ther ; 47(1): 58-60, 2009 Jan.
Article in En | MEDLINE | ID: mdl-19203540
Search on Google
Database: MEDLINE Main subject: Ruthenium Compounds / Indazoles / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Year: 2009 Type: Article
Search on Google
Database: MEDLINE Main subject: Ruthenium Compounds / Indazoles / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Year: 2009 Type: Article